Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Lung Cancer

  Free Subscription


Articles published in J Immunol

Retrieve available abstracts of 12 articles:
HTML format



Single Articles


    August 2022
  1. YOO KJ, Johannes K, Gonzalez LE, Patel A, et al
    LIGHT (TNFSF14) Costimulation Enhances Myeloid Cell Activation and Antitumor Immunity in the Setting of PD-1/PD-L1 and TIGIT Checkpoint Blockade.
    J Immunol. 2022;209:510-525.
    PubMed     Abstract available


    January 2022
  2. ZHENG Y, Chen Z, Zhou B, Chen S, et al
    PRMT5 Deficiency Enforces the Transcriptional and Epigenetic Programs of Klrg1(+)CD8(+) Terminal Effector T Cells and Promotes Cancer Development.
    J Immunol. 2022;208:501-513.
    PubMed     Abstract available


    September 2021
  3. LI Z, Gao Y, He C, Wei H, et al
    Purinergic Receptor P2Y6 Is a Negative Regulator of NK Cell Maturation and Function.
    J Immunol. 2021;207:1555-1565.
    PubMed     Abstract available


    April 2021
  4. CHEN CW, Bennion KB, Swift DA, Morrow KN, et al
    Tumor-Specific T Cells Exacerbate Mortality and Immune Dysregulation during Sepsis.
    J Immunol. 2021 Apr 28. pii: jimmunol.2000865. doi: 10.4049/jimmunol.2000865.
    PubMed     Abstract available


    March 2021
  5. AFROJ T, Mitsuhashi A, Ogino H, Saijo A, et al
    Blockade of PD-1/PD-L1 Pathway Enhances the Antigen-Presenting Capacity of Fibrocytes.
    J Immunol. 2021;206:1204-1214.
    PubMed     Abstract available


    November 2020
  6. YI FS, Zhang X, Zhai K, Huang ZY, et al
    TSAd Plays a Major Role in Myo9b-Mediated Suppression of Malignant Pleural Effusion by Regulating TH1/TH17 Cell Response.
    J Immunol. 2020;205:2926-2935.
    PubMed     Abstract available


  7. KOHNO M, Murakami J, Wu L, Chan ML, et al
    Foxp3(+) Regulatory T Cell Depletion after Nonablative Oligofractionated Irradiation Boosts the Abscopal Effects in Murine Malignant Mesothelioma.
    J Immunol. 2020;205:2519-2531.
    PubMed     Abstract available


    June 2020
  8. ZHANG Z, Huang X, Wang E, Huang Y, et al
    Suppression of Mll1-Complex by Stat3/Cebpbeta-Induced miR-21a/21b/181b Maintains the Accumulation, Homeostasis, and Immunosuppressive Function of Polymorphonuclear Myeloid-Derived Suppressor Cells.
    J Immunol. 2020;204:3400-3415.
    PubMed     Abstract available


    April 2020
  9. JOHNSON AM, Bullock BL, Neuwelt AJ, Poczobutt JM, et al
    Cancer Cell-Intrinsic Expression of MHC Class II Regulates the Immune Microenvironment and Response to Anti-PD-1 Therapy in Lung Adenocarcinoma.
    J Immunol. 2020;204:2295-2307.
    PubMed     Abstract available


    February 2020
  10. GHOUSE SM, Vadrevu SK, Manne S, Reese B, et al
    Therapeutic Targeting of Vasculature in the Premetastatic and Metastatic Niches Reduces Lung Metastasis.
    J Immunol. 2020;204:990-1000.
    PubMed     Abstract available


    January 2020
  11. NARASIMHAN PB, Eggert T, Zhu YP, Marcovecchio P, et al
    Patrolling Monocytes Control NK Cell Expression of Activating and Stimulatory Receptors to Curtail Lung Metastases.
    J Immunol. 2020;204:192-198.
    PubMed     Abstract available


    December 2019
  12. WANG L, Zeng W, Wang L, Wang Z, et al
    Naringenin Enhances the Antitumor Effect of Therapeutic Vaccines by Promoting Antigen Cross-Presentation.
    J Immunol. 2019 Dec 23. pii: jimmunol.1900278. doi: 10.4049/jimmunol.1900278.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: